Article
Updated incidence of EGFR mutation in Middle Eastern patients with non-small cell lung cancer: a 7-year study in a Lebanese institution.
BMC cancer - 9 Feb 2026
Kourie Hampig Raphael, Farhat Charbel, Zouein Joseph, Chebly Alain, Noujeim Fouad, Riachy Moussa, Dabar Georges, Harmouche Carine, Haber Bassem, Bacha Zeina Aoun, Kattan Joseph, Nasr Fady, Chahine Georges, Ghosn Marwan, Trak-Smayra Vivianne, ElKarak Fadi, Kesrouani Carole
Abstract excerpt
BACKGROUND: This study aims to update the mutational status of EGFR in non-small cell carcinoma (NSCLC), to analyze the spectrum of mutations found, and describe rare mutations in the Lebanese population. METHODS: In this retrospective study, patients diagnosed with NSCLC between 2016 and 2023 who underwent EGFR mutation testing were included. EGFR mutations from 2016 to 2019 were analyzed using real-time PCR on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.